Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Sagara
48 Ixazomib, an Oral Proteasome Inhibitor, Reduces Antibody Production by Depleting Plasma Cells in a T Cell Dependent Antigen Response Model
Related publications
Phase 1 Study of Ixazomib, an Investigational Proteasome Inhibitor, in Advanced Non-Hematologic Malignancies
Investigational New Drugs
Oncology
Pharmacology
Preclinical Evaluation of Antitumor Activity of the Proteasome Inhibitor MLN2238 (Ixazomib) in Hepatocellular Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
A Phase I Study to Assess the Mass Balance, Excretion, and Pharmacokinetics of [14c]-Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
T Cell Mediated Antibody Lnvariance in an Immune Response Against a Bacterial Carbohydrate Antigen Requires CD28/B7–1 Costimulation
Developmental Immunology
Inhibition of B-Cell Proliferation and Antibody Production by Mesenchymal Stromal Cells Is Mediated by T Cells
Stem Cells and Development
Developmental Biology
Hematology
Cell Biology
Production of Antigen-Specific Suppressive T Cell Factor by Radiation Leukemia Virus-Transformed Suppressor T Cells.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Analysis of Myeloma Cell Surface Antigen by New Monoclonal Antibody Which Recognizes Plasma Cell Relevant Antigen.
Japanese Journal of Clinical Immunology
Proteasome Inhibition Reduces Superantigen-Mediated T Cell Activation and the Severity of Psoriasis in a SCID-hu Model
Journal of Clinical Investigation
Medicine
T Cell Activation by Recombinant FcεRI Γ-Chain Immune Receptors: An Extracellular Spacer Domain Impairs Antigen-Dependent T Cell Activation but Not Antigen Recognition
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
